Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion
Sponsor:
Assiut University
Collaborators:
Information provided by (Responsible Party):
Amr Hatem Ahmed Mohammed,Assiut University
Tracking Information | |||
---|---|---|---|
First Submitted Date ICMJE | September 28, 2018 | ||
First Posted Date ICMJE | October 2, 2018 | ||
Last Update Posted Date | October 2, 2018 | ||
Actual Study Start Date ICMJE | November 2018 | ||
Estimated Primary Completion Date | November 2020 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures ICMJE |
Oswestry Disability index(Arabic version) 1 month[ Time Frame: 1 month ] an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. |
||
Original Primary Outcome Measures ICMJE | Same as current | ||
Current Secondary Outcome Measures ICMJE |
|
||
Descriptive Information | |||
Brief Title ICMJE | Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion |
||
Official Title ICMJE | Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion |
||
Brief Summary | A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure. |
||
Detailed Description | The first randomized controlled trial comparing minimally invasive TLIF and open TLIF. | ||
Study Type ICMJE | Interventional | ||
Study Phase | N/A | ||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Masking: Interventional Masking Description: Primary Purpose: Treatment |
||
Condition ICMJE | |||
Intervention ICMJE |
|
||
Study Arms |
|
||
Recruitment Information | |||
Recruitment Status ICMJE | Not yet recruiting | ||
Estimated Enrollment ICMJE |
60 | ||
Original Estimated Enrollment ICMJE | Same as current | ||
Estimated Study Completion Date | October 2021 | ||
Estimated Primary Completion Date | November 2020 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria ICMJE | Inclusion Criteria: - Adults more than 18 years of age and less than 65 years of age.. - Degenerative or isthmic spondylolithesis Grade 1,2 and 3. - Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression. - Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1. - Symptoms not responding to conservative treatment for at least 3 months. Exclusion Criteria: - Previous spinal fusion or instrumentation. - Spinal tumours, infection and fractures. - Patients with severe osteoporosis - BMI more than 35. - Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome) - Patients not willing to participate in the study | ||
Sex/Gender |
|
||
Ages | 18 Years and older (Adult, Older Adult) | ||
Accepts Healthy Volunteers | No | ||
Listed Location Countries ICMJE | |||
Removed Location Countries | |||
Administrative Information | Has Data Monitoring Committee | Yes | |
U.S. FDA-regulated Product |
Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No |
||
IPD Sharing Statement |
|
||
Responsible Party | Amr Hatem Ahmed Mohammed,Assiut University | ||
Study Sponsor ICMJE | Assiut University | ||
Collaborators ICMJE | |||
Investigators ICMJE |
|
||
PRS Account | Assiut University | ||
Verification Date | September 2018 | ||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
请使用微信扫码报名